Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Prostate cancer screening Stories

Colorectal Cancer Screening Effective At Reducing Mortality Rates
2013-09-28 04:55:59

redOrbit Staff & Wire Reports - Your Universe Online “Irrefutable” evidence that colorectal cancer (CRC) screening is effective at reducing the disease’s mortality rate should lead healthcare policymakers to shift resources currently devoted to breast and prostate cancer screenings to CRC testing, Belgian epidemiologist Philippe Autier will report this weekend. Autier, the vice president of population studies at the International Prevention Research Institute in France, will...

2013-09-23 11:37:22

Cancer patients can be accurately screened for major depression with a simple two-question survey, according to a study presented Sept. 23 at the American Society for Radiation Oncology's 55th Annual Meeting. The two-question screening test proved to be as accurate as a longer nine-question screening test. The study was presented at plenary session by William Small, Jr., MD, FASTRO, chair of the Department of Radiation Oncology of Loyola University Medical Center. "We found that a...

2013-09-20 08:26:03

LifeAgain Launches BlueMetric Select Term Life Insurance - First Program Designed for Men with Active Localized Prostate Cancer SAN DIEGO, Sept. 20, 2013 /PRNewswire/ -- LifeAgain Insurance Solutions Inc., a wholly-owned subsidiary of Cardium Therapeutics (NYSE MKT: CXM), today announced its recognition of National Prostate Cancer Awareness Month. September 2013 has been declared National Prostate Awareness Month by Presidential Proclamation to "raise awareness, support research,...

2013-09-18 12:31:33

Prostate Cancer Awareness Month highlights critical importance of early detection in saving lives MELVILLE, N.Y., Sept. 18, 2013 /PRNewswire/ -- LUGPA, representing more than 2,000 urologists nationwide, and Henry Schein Cares, the global corporate social responsibility program of Henry Schein, Inc., have partnered again this year to raise awareness among families across the country of the importance of putting prostate cancer check-ups on the calendar for the men in their lives....

2013-09-16 12:27:37

By the National Cancer Institute BETHESDA, Md., Sept. 16, 2013 /PRNewswire-USNewswire/ -- September is National Prostate Cancer Awareness Month. Prostate cancer is the second most commonly diagnosed type of cancer among American men. For reasons that are still unknown, African American men are more likely to get prostate cancer than men from other racial/ethnic groups. They are also twice as likely to die from prostate cancer as other men. (Logo:...

2013-09-12 12:12:56

3-gene biomarker gauges tumor's aggressiveness The level of expression of three genes associated with aging can be used to predict whether seemingly low-risk prostate cancer will remain slow-growing, according to researchers at the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center. Use of this three-gene biomarker, in conjunction with existing cancer-staging tests, could help physicians better determine which men with early prostate cancer can be safely...

2013-09-12 08:31:01

Urology experts clarify conflicting guidelines for PSA testing CHICAGO, Sept. 12, 2013 /PRNewswire/ -- LUGPA, an organization advocating for integrated and coordinated urological care with more than 2,000 physician experts across the U.S., has been carefully monitoring the recent controversy surrounding the use of prostate-specific antigen (PSA) testing for early detection of prostate cancer. Despite high-level evidence for the use of PSA testing as a screening tool and its role as a...

2013-09-10 04:22:15

- Company to Proceed with 2013 Commercial Launch of Novel Prostate Cancer Prognostic Test - CAMBRIDGE, Mass., Sept. 10, 2013 /PRNewswire/ -- Metamark Genetics, Inc., a privately-held biotechnology company, today announced positive results from a large clinical validation study of ProMark(TM), its biopsy-based prostate cancer prognostic test. The study, conducted in collaboration with Fred Saad, M.D., F.R.C.S., Professor and Chief, Division of Urology, Director of Urologic Oncology,...

2013-08-31 23:17:30

Master Prostate, a Great American Health product, just received a glowing review from Brett T. Person M.D. for Master Prostate, a prostate health supplement designed to encourage better overall prostate health. Destin, FL (PRWEB) August 31, 2013 Men are increasingly experiencing prostate problem, such as frequent trips to the bathroom. Dr. Person’s positive review explains the importance of health advice and check-ups but also explains the power of prostate health supplements. “I...

Propecia May Help Prevent Risk Of Prostate Cancer
2013-08-16 05:02:21

redOrbit Staff & Wire Reports - Your Universe Online Finasteride, a popular treatment for male pattern baldness also known as Propecia, can reduce a person’s risk of contracting prostate cancer by about one-third, according to research appearing in the August 15 issue of the New England Journal of Medicine. According to HealthDay News reporter Dennis Thompson, the researchers conducted an 18-year follow up to the Prostate Cancer Prevention Trial (PCPT). The PCPT, a study which...